ASX - Delayed Quote • AUD CardieX Limited (CDX.AX) Follow Compare 0.1050 0.0000 (0.00%) At close: January 17 at 4:10:20 PM GMT+11 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations CardieX Limited (ASX:CDX): When Will It Breakeven? With the business potentially at an important milestone, we thought we'd take a closer look at CardieX Limited's... Cardiex Announces Publication of Breakthrough Study Validating Noninvasive Fingertip Photoplethysmography (PPG) for Central Aortic Pressure Waveform Analysis Cardiex Limited (ASX: CDX), a global health technology company focused on cardiovascular diagnostics and arterial health solutions, today announced the publication of a peer-reviewed study validating its innovative method for measuring central aortic pressure—an important indicator of heart health—using a noninvasive fingertip sensor. The study, co-authored by Cardiex's team, was published in the respected journal Pulse. Performance Overview Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] Return CDX.AX S&P/ASX 200 [XJO] YTD +8.25% +1.85% 1-Year -13.07% +12.41% 3-Year -78.66% +12.04%